Zhao Q - Search Results

1

Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage III NSCLC.

Zhao Q, Chen G, Ye L, Shi S, Du S, Zeng Z, He J. Zhao Q, et al. Radiat Oncol. 2019 May 27;14(1):86. doi: 10.1186/s13014-019-1287-z. Radiat Oncol. 2019. PMID: 31133034 Free PMC article.

2

Liu J, Zhao Q, Deng W, Lu J, Xu X, Wang R, Li X, Yue J. Liu J, et al. Among authors: zhao q. Radiat Oncol. 2017 May 30;12(1):90. doi: 10.1186/s13014-017-0824-x. Radiat Oncol. 2017. PMID: 28558844 Free PMC article.

3

Clinical outcomes of stereotactic body radiotherapy for de novo pulmonary tumors in patients with completely resected early stage non-small cell lung cancer.

Zhao Q, Chen G, Ye L, Zeng Z, Shi S, He J. Zhao Q, et al. Cancer Manag Res. 2018 Nov 28;10:6391-6398. doi: 10.2147/CMAR.S180345. eCollection 2018. Cancer Manag Res. 2018. PMID: 30568500 Free PMC article.

4

Prognostic index score predicts outcome of patients with Stage I non-small cell lung cancer after stereotactic body radiation therapy.

Shi S, Ye L, Zhao Q, Hu Y, Huang Y, Chen G, Zeng Z, He J. Shi S, et al. Among authors: zhao q. Jpn J Clin Oncol. 2019 Apr 1;49(4):367-372. doi: 10.1093/jjco/hyy205. Jpn J Clin Oncol. 2019. PMID: 30715411

5

Emphysema quantification on computed tomography and its value in predicting radiation pneumonitis in lung cancer treated by stereotactic body radiotherapy.

Ye L, Zhang Y, Li T, Zhang X, Shi S, Zhao Q, Zeng Z, He J. Ye L, et al. Among authors: zhao q. J Radiat Res. 2019 May 1;60(3):371-379. doi: 10.1093/jrr/rrz007. J Radiat Res. 2019. PMID: 30968939 Free PMC article.

6

Prognosis and Risk Factors of Radiation-Induced Lymphopenia in Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy.

Zhao Q, Li T, Chen G, Zeng Z, He J. Zhao Q, et al. Front Oncol. 2020 Jan 24;9:1488. doi: 10.3389/fonc.2019.01488. eCollection 2019. Front Oncol. 2020. PMID: 32039000 Free PMC article.

7

DNA sensing and associated type 1 interferon signaling contributes to progression of radiation-induced liver injury.

Du S, Chen G, Yuan B, Hu Y, Yang P, Chen Y, Zhao Q, Zhou J, Fan J, Zeng Z. Du S, et al. Among authors: zhao q. Cell Mol Immunol. 2021 Jul;18(7):1718-1728. doi: 10.1038/s41423-020-0395-x. Epub 2020 Mar 19. Cell Mol Immunol. 2021. PMID: 32203191 Free PMC article.

8

Integration of radiotherapy with anti-PD-1 antibody for the treatment of intrahepatic or hilar cholangiocarcinoma: reflection from four cases.

Zhao Q, Chen Y, Du S, Yang X, Chen Y, Ji Y, Zeng Z. Zhao Q, et al. Cancer Biol Ther. 2021 Mar 4;22(3):175-183. doi: 10.1080/15384047.2020.1834792. Epub 2021 Mar 15. Cancer Biol Ther. 2021. PMID: 33722163 Free PMC article.

9

ALKBH5-Modified HMGB1-STING Activation Contributes to Radiation Induced Liver Disease via Innate Immune Response.

Chen G, Zhao Q, Yuan B, Wang B, Zhang Y, Li Z, Du S, Zeng Z. Chen G, et al. Among authors: zhao q. Int J Radiat Oncol Biol Phys. 2021 Oct 1;111(2):491-501. doi: 10.1016/j.ijrobp.2021.05.115. Epub 2021 May 24. Int J Radiat Oncol Biol Phys. 2021. PMID: 34044094

10

Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation.

Du SS, Chen GW, Yang P, Chen YX, Hu Y, Zhao QQ, Zhang Y, Liu R, Zheng DX, Zhou J, Fan J, Zeng ZC. Du SS, et al. Int J Radiat Oncol Biol Phys. 2022 Apr 1;112(5):1243-1255. doi: 10.1016/j.ijrobp.2021.12.162. Epub 2022 Jan 2. Int J Radiat Oncol Biol Phys. 2022. PMID: 34986380

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,268 results

Search Page

Filters